Drug Search Results

Fiboflapon

Alternative Names: fiboflapon, gsk-2190915, gsk2190915, gsk 2190915
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: FLAP Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fiboflapon

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Asthma

Trial	Phase	Trial Status	Disease	Primary Completion Date
2010-019466-81	P2	Completed	Asthma	2018-01-31
NCT01721135	P1	Withdrawn	Asthma	2014-12-01
NCT01471665	P2	Completed	Asthma	2012-05-01
2010-019095-70	P2	Completed	Asthma	2011-10-06

Recent News Events

Date	Type	Title
04/27/2024	PubMed	Impact of light on protective fractions of Cu in white wine: Influence of oxygen and bottle colour.
05/15/2024	PubMed	Comparison of Corneal Biomechanical Efficacy Between Rose Bengal-Green Light and Riboflavin-UVA Crosslinking.
04/30/2024	PubMed	Case Report: A rare treatable metabolic syndrome (Brown-Vialetto-Van Laere syndrome) masquerading as chronic inflammatory demyelinating polyneuropathy from Saudi Arabia.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions